Preliminary exploration of X-ray imaging features in triple-negative breast cancer with different expression levels of human epidermalgrowth factor receptor 2
10.12025/j.issn.1008-6358.2025.20250824
- VernacularTitle:不同人表皮生长因子受体2表达水平三阴性乳腺癌的X线影像特征初步探讨
- Author:
Xue ZHAO
1
;
Dengbin WANG
2
;
Lijun WANG
2
;
Yingjie ZHANG
1
;
Yixue GONG
1
;
Yan ZHANG
1
;
Yanmin YU
3
Author Information
1. Department of Radiology, Shanghai Second People’s Hospital, Shanghai 200011, China.
2. Department of Radiology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.
3. Department of Breast Surgery, Shanghai Second People’s Hospital, Shanghai 200011, China.
- Publication Type:Shortarticle
- Keywords:
digital breast tomosynthesis;
contrast-enhanced mammography;
triple-negative breast cancer;
human epidermal growth factor receptor 2
- From:
Chinese Journal of Clinical Medicine
2026;33(1):95-101
- CountryChina
- Language:Chinese
-
Abstract:
Objective To preliminary explore the imaging manifestations of digital breast tomosynthesis (DBT) and contrast-enhanced mammography (CEM) in triple-negative breast cancer (TNBC) patients with different levels of human epidermal growth factor receptor 2 (HER2) expression. Methods A retrospective analysis was conducted on TNBC patients who underwent preoperative DBT or CEM examinations at Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine from January 2018 to December 2019 and Shanghai Second People’s Hospital from January 2022 to May 2025. Clinical data, pathological and immunohistochemical results, and imaging data were collected. Results A total of 69 TNBC patients pathologically confirmed as invasive ductal carcinoma were included, among which 34 underwent DBT and 35 underwent CEM. Among these patients, 34 (49.28%) had HER2-low expression and 35 (50.72%) had HER2-zero expression. DBT results showed that the proportion of spiculation signs in HER2-low group (n＝14) was significantly higher than that in HER2-zero group (n＝20; P＝0.009, Padj＝0.045). However, there were no significant differences in breast density type, mass shape, or calcification between the two groups. CEM results showed that on low-energy images, the proportion of spiculation signs in the HER2-low group (n＝20) was higher than that in the HER2-zero group (n＝15; P＝0.011, Padj＝0.077). Results of CEM showed that on reconstructed images, differences in background parenchymal enhancement and mass enhancement patterns between the two groups were not statistically significant; in both groups, heterogeneous enhancement was the most common, followed by homogeneous enhancement, with ring enhancement being the least common. Conclusions TNBC with low HER2 expression and TNBC with zero HER2 expression may have potential differences in the presentation of spiculation signs on DBT. However, the correlation between CEM manifestations and TNBC with different HER2 expression levels requires further research.
